Aimin Zang

Aimin Zang

Auto-generated profile, based on publicly available information

Aimin Zang

Hebei Key Laboratory of Cancer Radiotherapy and Chemother-apy, Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2015 in Bangladesh Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
YJYouchao Jia
Youchao Jia
AZAimin Zang
Aimin Zang
YFYanguang Feng
Yanguang Feng
XLXiao-Fang Li
Xiao-Fang Li
KZKe Zhang
Ke Zhang
RHRan Huo
Ran Huo
It was aimed to explore the expression level of miRNA-486 and miRNA-499 in the plasma of lung cancer patients and analysis their differences in expre-ssion. The expression level of both miRNA-486 and miRNA-499 in the plasma of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) were lower than that of the control group (p<0.05) and the decrease was more obvious in NSCLC. Compare with the miRNA-499,expression quantity in NSCLC patients plasma. There was statistical significance difference (p<0.05) between III~Ⅳstage and I~II stage. The expression quantity of miRNA in plasma of patients with extensive-stage SCLC was lower than that of patients with limited-stage SCLC (p<0.05). The sensitivity and specificity of plasms miRNA-486 respectively were 88.5% and 83.3%. The expression of miRNA-499 and miRNA-486 in lung cancer patients were up-regulated, and might be closely related to the occurrence and prognosis of lung cancer, and might be used as potential screening and prognosis index for lung cancer.

1 September 2021 in Annals of Oncology
Verified
Journal Article
Closed access
YSY-K. Shi
Y-K. Shi
YQY. Qin
Y. Qin
WZW. Zhang
W. Zhang
XWX. Wang
X. Wang
HLHongmei Liu
Hongmei Liu
RZRenbin Zhao
Renbin Zhao